Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

VELOSEF

CEPHRADINE

Standard Dose
250MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview VELOSEF is listed in Drugs@FDA under application 061976 (ANDA).

Marketing status: Discontinued Active ingredient CEPHRADINE Form and strength INJECTABLE;INJECTION - 250MG/VIAL Sponsor APOTHECON Submission history Latest submission status date: 1977-02-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview VELOSEF is listed in Drugs@FDA under application 061976 (ANDA). Marketing status: Discontinued Active ingredient CEPHRADINE Form and strength INJECTABLE;INJECTION - 250MG/VIAL Sponsor APOTHECON Submission history Latest submission status date: 1977-02-09 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.